Clinical Research Studies
Current clinical trials investigating PEMF technology applications
Clinical effects of PEMF stimulation in patients with interstitial cystitis
Randomized controlled double-blind pilot study
Objective
Improvement in interstitial cystitis patients using Oska versus sham device
Primary Investigator
Dr. med. Bjorn Kaftan – Interstitial Cystitis and Pelvic Pain Center
Location
Clinic Luneburg, Germany
Status
Study completed 11/24. Awaiting publication in Spring 2025.
Clinical effects of PEMF stimulation in patients with endometriosis
Randomized controlled double-blind pilot study
Objective
Improvement in pain and inflammation secondary to endometriosis in patients using Oska versus a sham device
Primary Investigator
Prof. Dr. Sylvia Mechsner
Location
Charite Hospital – Endometriosis Center – Berlin, Germany
Status
Study underway. Interim results available at the World Endometriosis Conference, May 2025. Study expected to finish summer of 2025 and publish fall 2025.
Clinical effects of treatment of CRPS with PEMF
Double-blind randomized controlled pilot study
Objective
Improvement in pain, inflammation and quality of life in CRPS patients using Oska versus a sham device.
Primary Investigator
Prof. Dr. med. Janne Gierthmuhlen – Head of Interdisciplinary Pain and Palliative Outpatient Clinic
Location
Clinic for Anesthesiology and Surgical Intensive Care Medicine, Pain Therapy
Status
Study underway with expected completion in spring 2026.
| Study Name | Objective | Primary Investigator | Location | Status |
|---|---|---|---|---|
| Clinical effects of PEMF stimulation in patients with interstitial cystitis | Improvement in interstitial cystitis patients using Oska versus sham device | Dr. med. Bjorn Kaftan | Clinic Luneburg, Germany | Study completed 11/24. Awaiting publication in Spring 2025. |
| Clinical effects of PEMF stimulation in patients with endometriosis | Improvement in pain and inflammation secondary to endometriosis in patients using Oska versus a sham device | Prof. Dr. Sylvia Mechsner | Charite Hospital, Berlin, Germany | Study underway. Expected completion summer 2025. |
| Clinical effects of treatment of CRPS with PEMF | Improvement in pain, inflammation and quality of life in CRPS patients using Oska versus a sham device | Prof. Dr. med. Janne Gierthmuhlen | Clinic for Anesthesiology, Pain Therapy | Study underway with expected completion in spring 2026. |
These studies are exploring potential additional applications, not yet approved in the US.
Oska is an FDA cleared class 1 device used to treat pain in the US and a class IIa medical device approved to treat inflammation, improve healing and treat arthritis in Europe, England, Australia and all CE recognizing nations.